Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis

Molecular and Cellular Biology

Volumn 19, Issue 10, 1999, Pages 7203-7215

  Peruzzi, Francesca ^a   Prisco, Marco ^a   Dews, Michael ^a   Salomoni, Paolo ^a   Grassilli, Emanuela ^a   Romano, Gaetano ^a   Calabretta, Bruno ^a   Baserga, Renato ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL KINASE; PROTEIN BCL 2; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR;

APOPTOSIS; ARTICLE; CELL TYPE; ENZYME ACTIVATION; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

MURINAE;

EID: 0032827420     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.10.7203     Document Type: Article

References (95)

1. Avruch, J. 1998. Insulin signal transduction through protein kinase cascades. Mol. Cell. Biochem. 182:31-48.
2. Backer, J. M., M. G. Myers, Jr., X. J. Sun, D. J. Chi, S. E. Shoelson, M. Miralpeix, and M. F. White. 1993. Association of IRS-1 with insulin receptor and the phosphatidylinositol 3′-kinase. J. Biol. Chem. 268:8204-8212.
3. Baserga, R., A. Hongo, M. Rubini, M. Prisco, and B. Valentinis. 1997. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta 1332:105-126.
4. Baserga, R. 1997. The price of independence. Exp. Cell Res. 236:1-3.
5. Brunet, A., A. Bonni, M. J. Zigmond, M. Z. Lin, P. Jun, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis, and M. E. Greenberg. 1999. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96:857-868.
6. Burfeind, P., C. L. Chernicky, F. Rininsland, J. Ilan, and J. Ilan. 1996. Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc. Natl. Acad. Sci. USA 93:7263-7268.
7. Cardone, M. H., N. Roy, H. R. Stennicke, G. S. Salvesen, T. F. Franke, E. Stanbridge, S. Frisch, and J. C. Reed. 1998. Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318-1321.
8. Cobb, M. H., and E. J. Goldsmith. 1995. How MAP kinases are regulated. J. Biol. Chem. 270:14843-14846.
9. Craparo, A., R. Freund, and T. A. Gustafson. 1997. 14.3.3 interacts with the insulin-like growth factor I receptor and insulin receptor substrate 1 in a phosphoserine-dependent manner. J. Biol. Chem. 272:11663-11669.
10. Craparo, A., T. J. O'Neill, and T. A. Gustafson. 1995. Non-SH2 domains within insulin receptor substrate-1 and Shc mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor 1 receptor. J. Biol. Chem. 270:15639-15643.
11. D'Ambrosio, C., B. Valentinis, M. Prisco, K. Reiss, M. Rubini, and R. Baserga. 1997. Protective effect of the insulin-like growth factor I receptor on apoptosis induced by okadaic acid. Cancer Res. 57:3264-3271.
12. D'Ambrosio, C., A. Ferber, M. Resnicoff, and R. Baserga. 1996. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res. 56:4013-4020.
13. Datta, S. R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M. E. Greenberg. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241.
14. Del Peso, L., M. Gonzalez-Garcia, C. Page, R. Herrera, and G. Nunez. 1997. Interleukin-3 phosphorylation of BAD through the protein kinase Akt. Science 278:687-689.
15. Dent, P., T. Jelinek, D. K. Morrison, M. J. Weber, and T. W. Sturgill. 1995. Reversal of raf-1 activation by purified and membrane-associated protein phosphatases. Science 268:1902-1906.
16. Dews, M., I. Nishimoto, and R. Baserga. 1997. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins. Recept. Signal Transduct. 7:231-239.
17. Dudek, H., S. R. Datta, T. F. Franke, M. J. Birnbaum, R. Yao, G. M. Cooper, R. A. Segal, D. R. Kaplan, and M. E. Greenberg. 1997. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275: 661-665.
18. Dunn, S. E., R. A. Hardman, F. W. Kari, and C. J. Barrett. 1997. Insulin-like growth factor 1 (IGF-I) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res. 57:2687-2693.
19. Dunn, S. E., M. Wehrlich, N. J. H. Sharp, K. Reiss, G. Solomon, R. Hawkins, R. Baserga, and J. C. Barrett. 1998. A dominant negative mutant of the insulin-like growth factor 1 receptor inhibits the adhesion, invasion and metastasis of breast cancer. Cancer Res. 58:3353-3361.
20. Fantl, W. J., A. J. Muslin, A. Kikuchi, J. A. Martin, A. M. MacNicol, R. W. Gross, and L. T. Williams. 1994. Activation of Raf-1 by 14-3-3 proteins. Nature 371:612-614.
21. Franke, T. F., D. R. Kaplan, L. C. Cantley, and A. Toker. 1997. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-biphosphate. Science 275:665-668.
22. Freed, E., M. Symons, S. G. McDonald, F. McCormick, and R. Ruggieri. 1994. Binding of 14.3.3 proteins to the protein kinase Raf and effects on its activation. Science 265:1713-1716.
23. Frisch, S. M., and H. Francis. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:619-626.
24. Furlanetto, R. W., B. R. Dey, W. Lopaczynski, and S. P. Nissley. 1997. 14.3.3 proteins interact with the insulin-like growth factor receptor but not with the insulin receptor. Biochem. J. 327:765-771.
25. Gajewski, T. F., and C. B. Thompson. 1996. Apoptosis meets signal transduction: elimination of a BAD influence. Cell 87:589-592.
26. Greenberger, J. S., M. A. Sakakeeny, R. K. Humphries, C. J. Eaves, and R. J. Eckner. 1983. Demonstration of permanent factor-dependent multipotential (erythroid, neutrophil, basophil) hematopoietic progenitor cell lines. Proc. Natl. Acad. Sci. USA 80:2931-2935.
27. Harada, H., B. Becknell, M. Wilm, M. Mann, L. J. Huang, S. S. Taylor, J. D. Scott, and S. J. Korsmeyer. 1999. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell 3:413-422.
28. Harrington, E. A., M. R. Bennett, A. Fanidi, and G. I. Evan. 1994. c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13:3286-3295.
29. Hawley, R. G., F. H. Lieu, A. Z. Fong, and T. S. Hawley. 1994. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1:136-138.
30. Hongo, A., C. D'Ambrosio, M. Miura, A. Morrione, and R. Baserga. 1996. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Oncogene 12:1231-1238.
31. Hsing, A. Y., K. Kadomatsu, N. J. Bonham, and D. Danielpour. 1996. Regulation of apoptosis induced by transforming growth factor β1 in non-tumorigenic and tumorigenic rat prostatic epithelial cell lines. Cancer Res. 56:5146-5149.
32. Hugl, S. R., M. F. White, and C. J. Rhodes. 1998. Insulin-like growth factor I (IGF-I)-stimulated pancreatic β-cell growth is glucose-dependent. J. Biol. Chem. 273:17771-17779.
33. Jung, Y. K., M. Miura, and J. Yuan. 1996. Suppression of interleukin-1 beta converting enzyme-mediated cell death by insulin-like growth factor. J. Biol. Chem. 271:5112-5117.
34. Kennedy, S. G., A. J. Wagner, S. D. Conzen, J. Jordan, A. Bellacosa, P. N. Tsichlis, and N. Hay. 1997. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11:701-713.
35. Khokhlatchev, A. V., B. Canagarajah, J. Wilsbacher, M. Robinson, M. Atkinson, E. Goldsmith, and M. H. Cobb. 1998. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 93:605-615.
36. Khwaja, A., P. Rodriguez-Viciana, S. Wennstrom, P. H. Warne, and J. Downward. 1997. Matrix adhesion and ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/AAkt cellular survival pathway. EMBO J. 16:2783-2793.
37. Kosaki, A., K. Yamada, J. Suga, A. Otaka, and H. Kuzuya. 1998. 14.3.3β protein associates with insulin receptor substrate-1 and decreases insulin-stimulated phosphatidylinositol 3′-kinase activity in 3T3L1 adipocytes. J. Biol. Chem. 273:940-944.
38. Kulik, G., A. Klippel, and M. J. Weber. 1997. Antiapoptotic signaling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17:1595-1606.
39. Kulik, G., and M. J. Weber. 1998. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I. Mol. Cell. Biol. 18:6711-6718.
40. Lee, C. T., S. Wu, D. Gabrivolich, H. Chen, S. Nadaf-Rahrov, I. F. Ciernick, and D. P. Carbone. 1996. Antitumor effect of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines. Cancer Res. 56:3038-3041.
41. mpkk) in fibroblasts. J. Cell Biol. 122:1079-1088.
42. Li, S., A. Ferber, M. Miura, and R. Baserga. 1994. Mitogenicity and transforming activity of the insulin-like growth factor I receptor with mutations in the tyrosine kinase domain. J. Biol. Chem. 269:32558-32564.
43. Li, S., M. Resnicoff, and R. Baserga. 1996. Effects of mutations at serines 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor I receptor. J. Biol. Chem. 271:12254-12260.
44. Li, S., P. Janosch, M. Tanji, G. C. Rosenfeld, J. C. Waymire, H. Mischak, W. Kolch, and J. M. Sedivy. 1995. Regulation of Raf-1 kinase activity by the 14.3.3 family of proteins. EMBO J. 14:685-696.
45. Lin, T. H., Q. Chen, A. Howe, and H. L. Juliano. 1997. Cell anchorage permits efficient signal transduction between ras and its downstream kinases. J. Biol. Chem. 272:8849-8852.
46. Liu, Q., W. Ning, R. Dantzer, G. G. Freund, and K. W. Kelley. 1998. Activation of protein kinase C-zeta and phosphatidylinositol 3′-kinase and promotion of macrophage differentiation by insulin-like growth factor 1. J. Immunol. 160:1393-1401.
47. Liu, X., T. Turbyville, A. Fritz, and L. Whitesell. 1998. Inhibition of insulin-like growth factor 1 receptor expression in neuroblastoma cells induces the regression of established tumors in mice. Cancer Res. 58:5432-5438.
48. Long, L., R. Rubin, R. Baserga, and P. Brodt. 1995. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor I receptor. Cancer Res. 55:1006-1009.
49. Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
50. McCarthy, N. J., M. K. B. Whyte, C. S. Gilbert, and G. I. Evan. 1997. Inhibition of Ced3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136:215-227.
51. McCubrey, J. A., L. S. Stillman, M. W. Mayhew, P. A. Algate, R. A. Dellow, and M. Kaleko. 1991. Growth promoting effects of insulin-like growth factor 1 (IGF-1) on hematopoietic cells. Overexpression of introduced IGF-1 receptor abrogates interleukin-3 dependency of murine factor dependent cells by ligand dependent mechanism. Blood 78:921-929.
52. Miura, M., S. Li, and R. Baserga. 1995. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells. Cancer Res. 55:663-667.
53. S6K signaling during insulin, insulin-like growth factor-1, and interleukin-4 stimulation. J. Biol. Chem. 269:28783-28789.
54. Myers, M. G., Jr., X. J. Sun, B. Cheatham, B. R. Jachna, E. M. Glasheen, J. M. Backer, and M. F. White. 1993. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3′-kinase. Endocrinology 132:1421-1430.
55. Nakamura, S., H. Watanabe, M. Miura, and T. Sasaki. 1997. Effect of the insulin-like growth factor I receptor on ionizing radiation-induced cell death in mouse embryo fibroblasts. Exp. Cell Res. 235:287-294.
56. O'Connor, R., A. Kauffmann-Zeh, Y. Liu, S. Lehar, G. I. Evan, R. Baserga, and W. A. Blättler. 1997. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol. Cell. Biol. 17:427-435.
57. Parrizas, M., A. R. Saltiel, and D. LeRoith. 1997. Insulin-like growth factor I inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J. Biol. Chem. 272:154-161.
58. L gene product. Endocrinology 138:1355-1358.
59. Perrotti, D., S. Bonatti, R. Trotta, R. Martinet, T. Skorski, P. Salomoni, E. Grassilli, R. Iozzo, D. R. Cooper, and B. Calabretta. 1998. TLS/FUS, a proto-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis. EMBO J. 17:4442-4445.
60. Prager, D., H. L. Li, S. Asa, and S. Melmed. 1994. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor receptor mutant. Proc. Natl. Acad. Sci. USA 91:2181-2185.
61. Prisco, M., A. Hongo, M. G. Rizzo, A. Sacchi, and R. Baserga. 1997. The insulin-like growth factor I receptor as a physiological relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. Mol. Cell. Biol. 17:1084-1092.
62. Prisco, M., G. Romano, F. Peruzzi, B. Valentinis, and R. Baserga. 1999. Insulin and IGF-I receptors signaling in protection from apoptosis. Horm. Metab. Res. 31:80-89.
63. Pronk, G. J., J. McGlade, G. Pelicci, T. Pswson, and J. L. Bos. 1993. Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins. J. Biol. Chem. 268:5748-5753.
64. Pruett, W., Y. Yuan, E. Rose, A. G. Batzer, N. Harada, and E. Y. Skolnik. 1995. Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implications for Ras activation by insulin. Mol. Cell. Biol. 15:1778-1785.
65. Reiss, K., C. D'Ambrosio, X. Tu, C. Tu, and R. Baserga. 1998. Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect. Clin. Cancer Res. 4:2647-2655.
66. Resnicoff, M., D. Abraham, W. Yutanawiboonchai, H. Rotman, J. Kajstura, R. Rubin, P. Zoltick, and R. Baserga. 1995. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res. 55:2463-2469.
67. Resnicoff, M., J.-L. Burgaud, H. L. Rotman, D. Abraham, and R. Baserga. 1995. Correlation between apoptosis, tumorigenesis and levels of insulin-like growth factor I receptors. Cancer Res. 55:3739-3741.
68. Rininsland, F., T. R. Johnson, C. L. Chernicky, E. Schulze, B. Berfeind, J. Ilan, and J. Ilan. 1997. Suppression of insulin-like growth factor I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells. Proc. Natl. Acad. Sci. USA 94:5854-5859.
69. Rodriguez-Tarduchy, G., M. K. L. Collins, I. Garcia, and A. Lopez-Rivas. 1992. Insulin-like growth factor I inhibits apoptosis in IL-3 dependent hemopoietic cells. J. Immunol. 149:535-540.
70. Romano, G., M. Prisco, T. Zanocco-Marani, F. Peruzzi, B. Valentinis, and R. Baserga. 1999. Dissociation between resistance to apoptosis and the transformed phenotype in IGF-I receptor signaling. J. Cell. Biochem. 72:294-310.
71. Rubini, M., A. Hongo, C. D'Ambrosio, and R. Baserga. 1997. The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number. Exp. Cell Res. 230:284-292.
72. Salomoni, P., M. A. Wasik, R. F. Riedel, K. Reiss, J. K. Choi, T. Skorski, and B. Calabretta. 1998. Expression of constitutively active Raf-1 in the mitochondria restores antiapoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant. J. Exp. Med. 187:1995-2007.
73. ras-GTP formation. J. Biol. Chem. 269:10734-10738.
74. Sasaoka, T., D. W. Rose, B. H. Jhun, A. R. Saltiel, B. Draznin, and J. M. Olefsky. 1994. Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. J. Biol. Chem. 269:13689-13694.
75. Scheid, M. P., and V. Duronio. 1998. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation. Proc. Natl. Acad. Sci. USA 95:7439-7444.
76. Seely, B. L., D. R. Reichart, P. A. Staubs, B. H. Jhun, D. Hsu, H. Maegawa, K. L. Milarski, L. R. Saltiel, and J. M. Olefsky. 1995. Localization of the insulin-like growth factor 1 receptor binding sites for the SH2 domain proteins p85, Syp and GTPase activating protein. J. Biol. Chem. 270:19151-19157.
77. Sell, C., R. Baserga, and R. Rubin. 1995. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res. 55:303-306.
78. Shapiro, D. N., B. G. Jones, L. H. Shapiro, P. Dias, and P. J. Houghton. 1994. Antisense-mediated reduction in insulin-like growth factor 1 receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J. Clin. Investig. 94:1235-1242.
79. Singleton, J. R., V. M. Dixit, and E. L. Feldman. 1996. Type 1 insulin-like growth factor receptor activation regulates apoptotic proteins. J. Biol. Chem. 271:31791-31794.
80. Soneoka, Y., P. M. Cannon, E. E. Ramsdale, J. C. Griffiths, G. Romano, S. M. Kingsman, and A. J. Kingsman. 1995. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:628-633.
81. Songyang, Z., D. Baltimore, L. C. Cantley, D. R. Kaplan, and T. F. Franke. 1997. Interleukin-3-dependent survival by the Akt protein kinase. Proc. Natl. Acad. Sci. USA 94:11345-11350.
82. Tartare-Deckert, S., D. Sawka-Verhelle, J. Murdaca, and E. van Obberghen. 1995. Evidence for a differential interaction of Shc and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system. J. Biol. Chem. 270:23456-23460.
83. Turner, B. C., B. G. Haffty, L. Narayanan, J. Yuan, P. A. Havre, A. A. Gumbs, L. Kaplan, J. L. Burgaud, D. Carter, R. Baserga, and P. M. Glazer. 1997. Insulin-like growth factor 1 receptor overexpression mediates cellular resistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res. 57:3079-3083.
84. Valentinis, B., A. Morrione, F. Peruzzi, M. Prisco, K. Reiss, and R. Baserga. 1999. Anti-apoptotic signaling of the IGF-I receptor in fibroblasts following loss of matrix adhesion. Oncogene 18:1827-1836.
85. Valentinis, B., G. Romano, F. Peruzzi, A. Morrione, M. Prisco, S. Soddu, B. Cristofanelli, A. Sacchi, and R. Baserga. 1999. Growth and differentiation signals by the insulin-like growth factor 1 receptor in hemopoietic cells are mediated through different pathways. J. Biol. Chem. 274:12423-12430.
86. Valtieri, M., D. J. Tweardy, D. Caracciolo, K. Johnson, F. Mavilio, S. Altmann, D. Santoli, and G. Rovera. 1987. Cytokine dependent granulocytic differentiation. J. Immunol. 138:3829-3835.
87. Wang, H.-G., U. R. Rapp, and J. C. Reed. 1996. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87:629-638.
88. Wang, L. M., M. G. Myers, Jr., X. J. Sun, S. A. Aaronson, M. White, and J. H. Pierce. 1993. IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hemopoietic cells. Science 261:1591-1594.
89. White, M. F. 1998. The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol. Cell. Biochem. 182:3-11.
90. Wu, Y., M. Tewari, S. Cui, and R. Rubin. 1996. Activation of the insulin-like growth factor I receptor inhibits tumor necrosis factor-induced cell death. J. Cell. Physiol. 168:499-509.
91. L and Bcl-2, displaces Bax and promotes cell death. Cell 80:285-291.
92. Yenush, L., K. J. Makati, J. Smith-Hall, O. Ishibashi, M. G. Myers, Jr., and M. F. White. 1996. The pleckstrin homology domain is the principal link between the insulin receptor and IRS-1. J. Biol. Chem. 271:24300-24306.
93. Zamorano, J., H. Y. Wang, L.-M. Wang, J. H. Pierce, and A. D. Keegan. 1996. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. J. Immunol. 157:4926-4934.
94. L. Cell 87:619-628.
95. Zhou-Li, F., S. Q. Xu, M. Dews, and R. Baserga. 1997. Co-operation of simian virus 40 T antigen and insulin receptor substrate-1 in protection from apoptosis induced by interleukin-3 withdrawal. Oncogene 15:961-970.